Motor Development Assessment and Support for Children With Neurodevelopmental Disorders

NCT ID: NCT07323004

Last Updated: 2026-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-30

Study Completion Date

2027-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

On the one hand, it helps to understand the motor development of preschool children, so as to provide early intervention means for the prevention of motor retardation and promote the healthy development of preschool children, and on the other hand, different motor intervention strategies are formulated according to the developmental characteristics of children with different core symptoms. It is of great academic value to verify the effectiveness of the program through empirical research on exercise intervention and promote the improvement of motor and cognitive development of children with neurodevelopmental disorders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neurodevelopmental Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

typical development

This group consists of typically developing children aged 4-12 years. No intervention will be applied. The group will be used as a baseline for comparison and analysis of motor development and related health fitness indicators.

Group Type NO_INTERVENTION

No interventions assigned to this group

Special Intervention Group

This group includes children aged 4-12 years diagnosed with neurodevelopmental disorders. Participants will receive a combined intervention consisting of traditional rehabilitation therapy and a structured, characteristic exercise program designed to improve motor development and core health-related fitness.

Group Type EXPERIMENTAL

Characteristic Exercise Intervention

Intervention Type BEHAVIORAL

This intervention combines traditional rehabilitation techniques (e.g., occupational therapy and physical therapy focusing on fine and gross motor skills) with a structured, age-appropriate characteristic exercise program. The program includes dynamic balance training, sensory-motor integration activities, rhythmic movement games, and core stability exercises.

* Frequency: 3 sessions per week
* Duration: 45 minutes per session
* Total Intervention Period: 12 weeks
* Distinguishing Feature: The inclusion of customized play-based movement training and sensory-motor games designed specifically to support neurodevelopmental improvement in young children with motor delays.

General Intervention Group

This group includes children aged 4-12 years diagnosed with neurodevelopmental disorders. Participants will receive standard traditional rehabilitation therapy without the additional characteristic exercise intervention.

Group Type ACTIVE_COMPARATOR

Traditional Rehabilitation

Intervention Type BEHAVIORAL

Participants will receive conventional rehabilitation therapy, including basic motor skill exercises, postural control training, and therapist-led occupational therapy sessions aimed at improving daily motor function.

* Frequency: 3 sessions per week
* Duration: 45 minutes per session
* Total Intervention Period: 12 weeks
* Distinguishing Feature: This group receives only traditional rehabilitation techniques without any additional structured or characteristic physical activity component.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Characteristic Exercise Intervention

This intervention combines traditional rehabilitation techniques (e.g., occupational therapy and physical therapy focusing on fine and gross motor skills) with a structured, age-appropriate characteristic exercise program. The program includes dynamic balance training, sensory-motor integration activities, rhythmic movement games, and core stability exercises.

* Frequency: 3 sessions per week
* Duration: 45 minutes per session
* Total Intervention Period: 12 weeks
* Distinguishing Feature: The inclusion of customized play-based movement training and sensory-motor games designed specifically to support neurodevelopmental improvement in young children with motor delays.

Intervention Type BEHAVIORAL

Traditional Rehabilitation

Participants will receive conventional rehabilitation therapy, including basic motor skill exercises, postural control training, and therapist-led occupational therapy sessions aimed at improving daily motor function.

* Frequency: 3 sessions per week
* Duration: 45 minutes per session
* Total Intervention Period: 12 weeks
* Distinguishing Feature: This group receives only traditional rehabilitation techniques without any additional structured or characteristic physical activity component.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children aged 4 to 12 years
* Born at full term (gestational age ≥ 37 weeks and \< 42 weeks)
* Provided informed consent signed by their legal guardian
* For the ADHD group:
* Diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) by a qualified physician (e.g., child psychiatrist or psychologist) according to DSM-5 diagnostic criteria
* For the typical development (control) group:
* No symptoms related to ADHD (e.g., inattention, hyperactivity, impulsivity)
* Normal scores on parent- and teacher-rated behavioral questionnaires (e.g., CBCL, SDQ)
* No history of neurological or psychiatric disorders

Exclusion Criteria

* Diagnosis of other neurodevelopmental disorders, such as:
* Autism Spectrum Disorder (ASD)
* Learning disabilities
* Epilepsy, cerebral palsy, or other neurological conditions
* Developmental quotient (DQ) \< 85, as measured by standardized tools (e.g., Gesell scale)
* Significant visual or hearing impairments, or congenital malformations
* History of high-risk birth events, including but not limited to:
* Severe birth asphyxia
* Intrauterine infections
* Presence of genetic or metabolic disorders, or severe dysfunction of vital organs
* For the ADHD group: comorbid psychiatric conditions (e.g., schizophrenia, severe mood disorders)
Minimum Eligible Age

4 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aiyoudong Children and Youth Sports Health Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

China Institute of Sport Science

Beijing, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

yanfeng zhang, Ph. D

Role: CONTACT

+8613641060197

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

yanfeng zhang

Role: primary

+8613641060197

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022YFC3600204

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

Basic-2461

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.